Dana Flanders
Stock Analyst at Guggenheim
(0.10)
# 4,354
Out of 4,981 analysts
7
Total ratings
16.67%
Success rate
-19.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dana Flanders
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VALN Valneva SE | Maintains: Buy | $17 → $15 | $8.92 | +68.16% | 1 | Mar 24, 2025 | |
| SCYX SCYNEXIS | Initiates: Buy | $25 | $1.12 | +2,132.14% | 1 | Jan 22, 2021 | |
| PCRX Pacira BioSciences | Initiates: Neutral | n/a | $27.12 | - | 1 | May 27, 2020 | |
| HRTX Heron Therapeutics | Initiates: Buy | $24 | $1.26 | +1,804.76% | 1 | May 27, 2020 | |
| COLL Collegium Pharmaceutical | Initiates: Neutral | n/a | $37.33 | - | 1 | May 27, 2020 | |
| EBS Emergent BioSolutions | Upgrades: Buy | $60 → $75 | $8.14 | +821.38% | 2 | Nov 2, 2018 |
Valneva SE
Mar 24, 2025
Maintains: Buy
Price Target: $17 → $15
Current: $8.92
Upside: +68.16%
SCYNEXIS
Jan 22, 2021
Initiates: Buy
Price Target: $25
Current: $1.12
Upside: +2,132.14%
Pacira BioSciences
May 27, 2020
Initiates: Neutral
Price Target: n/a
Current: $27.12
Upside: -
Heron Therapeutics
May 27, 2020
Initiates: Buy
Price Target: $24
Current: $1.26
Upside: +1,804.76%
Collegium Pharmaceutical
May 27, 2020
Initiates: Neutral
Price Target: n/a
Current: $37.33
Upside: -
Emergent BioSolutions
Nov 2, 2018
Upgrades: Buy
Price Target: $60 → $75
Current: $8.14
Upside: +821.38%